Extensive condyloma acuminata treated with imiquimod 5% cream: A case report

Clinical and Experimental Dermatology, Supplement

Volumn 28, Issue 1, 2003, Pages 51-54

  Cox, J T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; PODOPHYLLOTOXIN; TRICHLOROACETIC ACID; AMINOQUINOLINE DERIVATIVE; IMMUNOLOGICAL ADJUVANT; LIQUID NITROGEN;

ADULT; ARTICLE; CASE REPORT; CONDYLOMA ACUMINATUM; CRYOTHERAPY; DISTRESS SYNDROME; FEMALE; FOLLOW UP; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 6; INFLAMMATION; LOW LEVEL LASER THERAPY; PAIN; PRIORITY JOURNAL; RECURRENCE RISK; SEXUALLY TRANSMITTED DISEASE; SIDE EFFECT; TREATMENT OUTCOME; WART VIRUS; ANUS DISEASE; GYNECOLOGIC DISEASE; OINTMENT; TOPICAL DRUG ADMINISTRATION; ANAMNESIS; MORPHOLOGY; SEXUAL TRANSMISSION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; ADULT; AMINOQUINOLINES; ANUS DISEASES; CONDYLOMATA ACUMINATA; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; OINTMENTS; TREATMENT OUTCOME;

EID: 1542644911     PISSN: 09663487     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.28.s1.17.x     Document Type: Article

References (13)

1. Tyring SK. Immune response modifiers: a new paradigm in the treatment of human papillomavirus. Curr Therap Res 2000; 61: 884-96.
2. De-Villiers E. Human pathogenic papillomavirus types: an update. Current Top Microbiol Immunol 1994; 186: 1-12.
3. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102: 3-8.
4. Franco EL, Rohan TE, Villa LL. Epidemiological evidence and human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst 1999; 91: 506-11.
5. Maw RD, Reitano M, Roy M. An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle. Int J STD AIDS 1998; 9: 571-8.
6. Edwards L, Ferenezy A, Eron L et al. Self administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998; 134: 25-30.
7. Buck HW, Fortier M, Knudsen J, Paavonen J. Imiquimod 5% cream in the treatment of anogenital warts in female patients. Int J Gyn Obs 2002; 77: 231-8.
8. Gollnick H, Barasso R, Jappe U et al. Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day. Int J STD AIDS 2001; 12: 22-8.
9. Fife KH, Ferenczy A, Douglas JM, Brown DR, Smith M, Owens ML and the HPV Study Group. Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily or three times a day. Sex Trans Dis 2001; 28: 226-31.
10. Garland SM, Sellors JW, Wikstrom A et al. and the Imiquimod Study Group. Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts - results of an open-label, multicentre Phase IIIB trial. Int J STD AIDS 2001; 12: 722-9.
11. von Krogh G, Lacey CJ, Gross G, Barrasso R, Schneider A. European course on HPV-associated pathology: guidelines for the diagnosis and management of anogenital warts. Sex Trans Infect 2000; 76: 162-8.
12. Centers for Disease Control & Prevention (CDC). Sexually transmitted diseases treatment guidelines. Morbid Morta Wkly Rep (MMWR) 2002; 51 (RR 6): 53-6.
13. Tatti SA, Belardi G, Marini MA et al. Consenso en la metodologia diagnostica y terapeutica para las verrugas anogenitales. Rev Obs Ginecol Latin-Am 2001; 59: 3-16.